2,678 Cigna Group $CI Shares Sold by Parallel Advisors LLC

Parallel Advisors LLC decreased its position in shares of Cigna Group (NYSE:CI) by 45.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,216 shares of the health services provider’s stock after selling 2,678 shares during the period. Parallel Advisors LLC’s holdings in Cigna Group were worth $874,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Plancorp LLC lifted its position in shares of Cigna Group by 77.1% during the 3rd quarter. Plancorp LLC now owns 2,323 shares of the health services provider’s stock worth $693,000 after buying an additional 1,011 shares during the last quarter. Alps Advisors Inc. grew its stake in shares of Cigna Group by 40.2% during the third quarter. Alps Advisors Inc. now owns 11,529 shares of the health services provider’s stock worth $3,134,000 after buying an additional 3,307 shares during the last quarter. Calamos Advisors LLC grew its position in Cigna Group by 2.1% during the 3rd quarter. Calamos Advisors LLC now owns 47,967 shares of the health services provider’s stock worth $13,039,000 after acquiring an additional 970 shares during the last quarter. Alta Advisers Ltd boosted its stake in shares of Cigna Group by 81.6% during the third quarter. Alta Advisers Ltd now owns 1,896 shares of the health services provider’s stock valued at $515,000 after purchasing an additional 852 shares in the last quarter. Finally, Principle Wealth Partners LLC grew its holdings in shares of Cigna Group by 1.6% during the third quarter. Principle Wealth Partners LLC now owns 6,396 shares of the health services provider’s stock worth $1,739,000 after purchasing an additional 101 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Recent coverage says strong Q3 growth has lifted Cigna’s 2026 earnings outlook, offering a favorable signal about business performance and the company’s earnings trajectory. The Cigna Group stock: Higher outlook follows strong Q3 performance
• Positive Sentiment: Barclays raised its price target to $320 from $310, implying potential upside from the referenced $302.30 price. However, it maintained an “equal weight” rating, indicating a balanced rather than strongly bullish view. Barclays price target update
• Neutral Sentiment: The Cigna Group Foundation awarded $3.45 million to 23 nonprofits supporting housing stability and mental health for veterans and their families. This highlights community investment but is not likely to have a significant direct effect on earnings. Cigna Foundation veteran grants
• Neutral Sentiment: Cigna’s CFO is scheduled to speak at the UBS Global Healthcare Conference, which could provide investors with updates but is not itself a financial announcement. UBS Global Healthcare Conference appearance
• Neutral Sentiment: Cigna Healthcare Hong Kong is expanding access to Headspace’s self-guided mental-wellbeing resources. The partnership may support its service offering, though the report provides no financial impact. Headspace resources in Hong Kong
• Negative Sentiment: Guggenheim cut its price target for Cigna, a cautious counterpoint to Barclays’ increase. The report provided here does not specify the revised target or rating. Guggenheim price target update

Cigna Group Price Performance

Shares of NYSE:CI opened at $302.30 on Wednesday. The firm has a market capitalization of $79.88 billion, a PE ratio of 13.34, a P/E/G ratio of 1.10 and a beta of 0.25. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $286.66 and a two-hundred day moving average price of $282.38. Cigna Group has a twelve month low of $257.85 and a twelve month high of $318.05.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping analysts’ consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.57% and a net margin of 2.09%. The firm had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. During the same period last year, the company earned $7.83 earnings per share. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. Equities analysts forecast that Cigna Group will post 30.70 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is currently 27.54%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on CI shares. Sanford C. Bernstein reissued an “outperform” rating on shares of Cigna Group in a research note on Friday, October 2nd. UBS Group reissued a “buy” rating on shares of Cigna Group in a research report on Thursday, October 1st. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Sunday. Piper Sandler reissued an “overweight” rating on shares of Cigna Group in a research note on Friday, October 23rd. Finally, Royal Bank Of Canada restated an “outperform” rating and set a $337.00 price objective on shares of Cigna Group in a report on Thursday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $336.20.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

About Cigna Group

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.